| DC Field | Value | Language |
|---|
| dc.contributor.author | Soldatov, V. O. | - |
| dc.contributor.author | Kubekina, M. V. | - |
| dc.contributor.author | Skorkina, M. Yu. | - |
| dc.contributor.author | Korokin, M. V. | - |
| dc.contributor.author | Pokrovskiy, M. V. | - |
| dc.contributor.author | Deykin, A. V. | - |
| dc.contributor.author | Angelova, P. R. | - |
| dc.date.accessioned | 2025-05-15T07:01:45Z | - |
| dc.date.available | 2025-05-15T07:01:45Z | - |
| dc.date.issued | 2022 | - |
| dc.identifier.citation | Current advances in gene therapy of mitochondrial diseases / V.O. Soldatov, M.V. Kubekina, Skorkina M.Yu. [et al.] // Journal of Translational Medicine. - 2022. - Vol.20, №1.-Art. 562. - Doi: 10.1186/s12967-022-03685-0. | ru |
| dc.identifier.uri | http://dspace.bsuedu.ru/handle/123456789/65190 | - |
| dc.description.abstract | Mitochondrial diseases (MD) are a heterogeneous group of multisystem disorders involving metabolic errors. Understanding the dynamics of mitochondrial genetics supporting mitochondrial biogenesis is especially important for the development of strategies for the treatment of rare and difficult-to-diagnose diseases. Gene therapy is one of the methods for correcting mitochondrial disorders | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | gene therapy | ru |
| dc.subject | mitochondrial diseases | ru |
| dc.subject | energy metabolism | ru |
| dc.subject | mitochondrial DNA | ru |
| dc.subject | heteroplasmy | ru |
| dc.title | Current advances in gene therapy of mitochondrial diseases | ru |
| dc.type | Article | ru |
| Appears in Collections: | Статьи из периодических изданий и сборников (на иностранных языках) = Articles from periodicals and collections (in foreign languages)
|
